Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s subsidiary Kannaway has launched its operations in Hong Kong.
”Our first Asian expansion has been a fantastic success in Japan and we now look forward to bringing our high-quality cannabidiol (CBD) products to Hong Kong as well,”
Kannaway® CEO Blake Schroeder said.
“Hemp has a long history in the region and, according to MJBizDaily, China is the world’s largest hemp producer.
Now, with the global popularity of CBD on the rise, we’re seeing the citizens of Hong Kong who want to go back to their roots use hemp-derived CBD.”
Kannaway® will be hosting regional events to educate current and potential Brand Ambassadors on the many potential wellness benefits and financial opportunities of hemp-derived CBD oil.
Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products.
Kannaway® hosts regular sales meetings and conferences across the globe, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products. For more information please visit www.kannaway.com
Get more information, facts and figures about Kannaway, click here for the Kannaway overview.